Skip to main content

Helus Pharma Inc 6-K, filed Nov 16, 2026

Helus Pharma Inc. (HELP)

6-K 2026-11-16 For: 2026-11-15
View Original
Added on November 16, 2026

About this 6-K

Helus Pharma Inc filed this 6-K on November 16, 2026.

Helus Pharma Inc. will present topline results from its Phase 3 APPROACH study evaluating HLP003 in major depressive disorder during a webcast at 8:00 a.m. EDT on November 16, 2026. AI summary